Evommune, Inc. (EVMN) financial statements and ratios from SEC XBRL: revenue $13.00M (TTM), net margin -529.8%, revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $13.00M |
| Net Margin | -529.8% |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | -93.2% |
| FCF Growth (YoY) | 15.4% |
| Price / Book | 1.82 |
| Price / Sales | 50.63 |
| FCF Yield | -31.9% |
| Altman Z-Score | 13.77 (safe) |
| Sector P/E (Healthcare) | 21.7 |
EVMN overview · EVMN earnings · EVMN KPIs · EVMN investor relations · EVMN ownership · EVMN peers · EVMN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.